Xilio Therapeutics, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1286468,
    "name": "Xilio Therapeutics, Inc.",
    "stock_name": "Xilio Therapeutics, Inc.",
    "full_name": "Xilio Therapeutics, Inc.",
    "name_url": "stocks-analysis/xilio-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.68",
    "chg": -0.03,
    "chgp": "-4.11%",
    "dir": -1,
    "prev_price": "0.71",
    "mcapval": "36.06",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US98422T1007",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "1.36 M",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/xilio-therapeutics-inc-1286468-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Xilio Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xilio-therapeutics-inc-technically-bullish-or-bearish-3547691",
        "imagepath": "",
        "date": "2025-09-20 20:00:51",
        "description": "As of 12 September 2025, the technical trend for Xilio Therapeutics, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI shows bearish conditions on the weekly but no signal on the monthly. Bollinger Bands indicate bullishness weekly but mildly bearish monthly. Moving averages are mildly bearish on the daily, and the KST is mildly bullish weekly but bearish monthly. Dow Theory shows no trend weekly and mildly bearish monthly, while OBV is bullish monthly but shows no trend weekly.\n\nIn terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 4.62% and 7.98% compared to 1.05% and 2.33%, respectively. However, year-to-date and one-year returns are significantly negative at -20.06% and -6.3%, contrasting shar..."
      },
      {
        "title": "Is Xilio Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-xilio-therapeutics-inc-overvalued-or-undervalued-3543989",
        "imagepath": "",
        "date": "2025-09-20 18:34:30",
        "description": "As of 8 August 2024, the valuation grade for Xilio Therapeutics, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its high Price to Book Value of 3.39 and low EV to EBIT of 0.91, alongside a troubling ROE of -507.61%. Compared to peers, Xilio's valuation metrics are concerning; for instance, ADC Therapeutics SA has a more negative EV to EBITDA of -4.7475, while Kinnate Biopharma, Inc. shows a more favorable EV to EBITDA of 0.2381.\n\nIn terms of stock performance, Xilio has underperformed significantly against the S&P 500, with a year-to-date return of -20.06% compared to the index's 12.22%. This stark contrast reinforces the notion that the stock may be overvalued in the current market context...."
      }
    ],
    "total": 6,
    "sid": "1286468",
    "stock_news_url": "https://www.marketsmojo.com/news/xilio-therapeutics-inc-1286468"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Xilio Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:00:51

As of 12 September 2025, the technical trend for Xilio Therapeutics, Inc. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The MACD is mildly bullish on both weekly and monthly time frames, while the RSI shows bearish conditions on the weekly but no signal on the monthly. Bollinger Bands indicate bullishness weekly but mildly bearish monthly. Moving averages are mildly bearish on the daily, and the KST is mildly bullish weekly but bearish monthly. Dow Theory shows no trend weekly and mildly bearish monthly, while OBV is bullish monthly but shows no trend weekly. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 4.62% and 7.98% compared to 1.05% and 2.33%, respectively. However, year-to-date and one-year returns are significantly negative at -20.06% and -6.3%, contrasting shar...

Is Xilio Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:34:30

As of 8 August 2024, the valuation grade for Xilio Therapeutics, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its high Price to Book Value of 3.39 and low EV to EBIT of 0.91, alongside a troubling ROE of -507.61%. Compared to peers, Xilio's valuation metrics are concerning; for instance, ADC Therapeutics SA has a more negative EV to EBITDA of -4.7475, while Kinnate Biopharma, Inc. shows a more favorable EV to EBITDA of 0.2381. In terms of stock performance, Xilio has underperformed significantly against the S&P 500, with a year-to-date return of -20.06% compared to the index's 12.22%. This stark contrast reinforces the notion that the stock may be overvalued in the current market context....

View All News